Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients

With the changing epidemiology of COVID-19 and its impact on our daily lives, there is still an unmet need of COVID-19 therapies treating early infections to prevent progression. The current study was a randomized, parallel, double-blind, placebo-controlled trial. Ninety SARS-CoV-2 positive patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Klussmann, Jens Peter, Grosheva, Maria, Meiser, Peter, Lehmann, Clara, Nagy, Eszter, Szijártó, Valéria, Nagy, Gábor, Konrat, Robert, Flegel, Michael, Holzer, Frank, Groß, Dorothea, Steinmetz, Charlotte, Scherer, Barbara, Gruell, Henning, Schlotz, Maike, Klein, Florian, de Aragão, Paula Aguiar, Morr, Henning, Al Saleh, Helal, Bilstein, Andreas, Russo, Belisa, Müller-Scholtz, Susanne, Acikel, Cengizhan, Sahin, Hacer, Werkhäuser, Nina, Allekotte, Silke, Mösges, Ralph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132439/
https://www.ncbi.nlm.nih.gov/pubmed/37100830
http://dx.doi.org/10.1038/s41598-023-32546-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132439/
https://www.ncbi.nlm.nih.gov/pubmed/37100830
http://dx.doi.org/10.1038/s41598-023-32546-z

Ejemplares similares